Your therapy is cryopreserved and ready to change a patient's life. Is the cryogenic ecosystem in place to ensure you do not trip at the last mile?
Modern medicine is evolving to support the advent of cellular-based therapies and treatments. These therapies provide new promise and opportunity to so many patients. However, cellular-based therapies have specific handling requirements related to temperature.
In this case, shelf-life is only preserved when the temperature can be maintained below the glass transition of water (Tg). Any increase in temperature can result in unintended damage to cellular products. Whether you are handling vitrified eggs and embryos, or you are handling a blockbuster in CAR-T, your cryogenic eco-system needs to be rock solid.
Join this webinar to gain perspective from two global leaders with decades of experience in handling inventories of high value, cryopreserved cellular products.
Moderator: David Lewandowski, Global Product Marketing Manager,
Brooks Life Science Systems
Speaker: Kaj Rydman, President
Speaker: Albert Ribickas, BMT/QC Laboratories Manager, Cell Therapies Facility
Moffitt Cancer Center
Date: October 25th 2018
Time: 4pm BST | 11am EST | 8am PST
How: register here
The webinar will be available on demand so if you can't make the live session, register your details and we'll send you the recording.